Skip to content
Their Record

Senate Roll Call 252, 105th Congress · September 23, 1997

To require that entities and individuals accredited to conduct reviews of device notifications be subject to the conflict of interest standards that apply to employees of the Food and Drug Administration. — (SENATE REJECTED DURBIN AMENDMENT NO. 1140 TO AMENDMENT NO. 1130, TO REQUIRE THAT ENTITIES AND INDIVIDUALS ACCREDITED TO CONDUCT REVIEW OF DEVICE NOTIFICATIONS BE SUBJECT TO THE CONFLICT OF INTEREST STANDARDS THAT APPLY TO EMPLOYEES OF THE FOOD AND DRUG ADMINISTRATION. .)

Question before the chamber: On the Amendment

40 yea · 59 nayAmendment Rejected1 not voting or present
Democrat39 yea · 6 nay
Republican0 yea · 52 nay
Independent1 yea · 1 nay

Solid = yea, faded = nay.

The measure

S. 830 ↗

Food and Drug Administration Modernization Act of 1997

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

  • Health CareDirection unreadable — not scored

    excluded:model-unclear (0.90) FDA regulatory conflict-of-interest standards do not directly address health insurance coverage.

    Tagged by: policy-area:Health

    Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (40)

Nay (59)

Not voting or present (1)

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.